BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15909172)

  • 1. Acute putaminal necrosis and white matter demyelination in a child with subnormal copper metabolism in Wilson disease: MR imaging and spectroscopic findings.
    Juan CJ; Chen CY; Liu YJ; Chung HW; Chin SC; Hsueh CJ; Chu H; Zimmerman RA
    Neuroradiology; 2005 Jun; 47(6):401-5. PubMed ID: 15909172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical correlates of cerebral water diffusion in Wilson disease.
    Favrole P; Chabriat H; Guichard JP; Woimant F
    Neurology; 2006 Feb; 66(3):384-9. PubMed ID: 16476937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of diffusion weighted magnetic resonance imaging and spectroscopy in the diagnosis and follow-up of hepatolenticular degeneration.
    Xue P; Liu Y; Ma XH; Chen Y; Zhang SJ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Oct; 34(5):497-502. PubMed ID: 23134827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kayser-Fleischer ring with keratoconus: a coincidence? A case report.
    Hu P; Lin L; Wu Z; Jin X; Ni H
    BMC Ophthalmol; 2020 May; 20(1):190. PubMed ID: 32404122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-hypoxic early selective putaminal necrosis followed by delayed extensive sub-cortical demyelination.
    Sharma VK; Tan JH
    Brain Inj; 2007 Oct; 21(11):1199-202. PubMed ID: 17882629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of MRI changes in Wilson disease and its correlation with clinical features and outcome.
    Ranjan A; Kalita J; Kumar S; Bhoi SK; Misra UK
    Clin Neurol Neurosurg; 2015 Nov; 138():31-6. PubMed ID: 26278999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical characteristics of patients with delayed hepatolenticular degeneration].
    Zhou XX; Qin HL; He RX; Chen DB; Wu C; Feng L; Li XH; Liang XL
    Zhonghua Nei Ke Za Zhi; 2019 Jul; 58(7):501-507. PubMed ID: 31269566
    [No Abstract]   [Full Text] [Related]  

  • 8. Is it possible to diagnose Wilson disease with a piece of skin?
    Eşrefoğlu M; Gül M; Seyhan M; Selimoğlu MA
    Ultrastruct Pathol; 2009 Dec; 33(6):265-8. PubMed ID: 19929173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance proton spectroscopy of the brain in Wilson's disease.
    Kraft E; Trenkwalder C; Then Bergh F; Auer DP
    J Neurol; 1999 Aug; 246(8):693-9. PubMed ID: 10460447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Kayser-Fleischer ring using Scheimpflug imaging.
    Telinius N; Ott P; Hjortdal J
    Acta Ophthalmol; 2017 May; 95(3):e248-e249. PubMed ID: 27683232
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of Kayser-Fleischer ring in Wilson disease by anterior segment optical coherence tomography.
    Sridhar MS; Rangaraju A; Anbarasu K; Reddy SP; Daga S; Jayalakshmi S; Shaik B
    Indian J Ophthalmol; 2017 May; 65(5):354-357. PubMed ID: 28573989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osmotic demyelination syndrome diagnosed radiologically during Wilson's disease investigation.
    Júnior SFA; Ventura N; Marchiori E
    Eur J Neurol; 2021 Feb; 28(2):726-728. PubMed ID: 33022802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion MR imaging changes associated with Wilson disease.
    Sener RN
    AJNR Am J Neuroradiol; 2003 May; 24(5):965-7. PubMed ID: 12748103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain iron accumulation in Wilson disease: a post mortem 7 Tesla MRI - histopathological study.
    Dusek P; Bahn E; Litwin T; Jabłonka-Salach K; Łuciuk A; Huelnhagen T; Madai VI; Dieringer MA; Bulska E; Knauth M; Niendorf T; Sobesky J; Paul F; Schneider SA; Czlonkowska A; Brück W; Wegner C; Wuerfel J
    Neuropathol Appl Neurobiol; 2017 Oct; 43(6):514-532. PubMed ID: 27543917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythrocyte metabolism and antioxidant status of patients with Wilson disease with hemolytic anemia.
    Attri S; Sharma N; Jahagirdar S; Thapa BR; Prasad R
    Pediatr Res; 2006 Apr; 59(4 Pt 1):593-7. PubMed ID: 16549536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of neurological Wilson's disease without Kayser-Fleischer ring.
    Youn J; Kim JS; Kim HT; Lee JY; Lee PH; Ki CS; Cho JW
    J Neurol Sci; 2012 Dec; 323(1-2):183-6. PubMed ID: 23043908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilateral optic atrophy in Wilson disease: A case report and literature review.
    Chen F; Chen C; Zhang Y; Jiang L; Huang Z; Chen FK
    Clin Res Hepatol Gastroenterol; 2024 Mar; 48(3):102299. PubMed ID: 38365087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of liver transplantation on neurological manifestations in Wilson disease.
    Stracciari A; Tempestini A; Borghi A; Guarino M
    Arch Neurol; 2000 Mar; 57(3):384-6. PubMed ID: 10714666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation between portal-systemic encephalopathy and neurodegenerative disorders in patients with Wilson disease: H-1 MR spectroscopy.
    Van Den Heuvel AG; Van der Grond J; Van Rooij LG; Van Wassenaer-van Hall HN; Hoogenraad TU; Mali WP
    Radiology; 1997 May; 203(2):539-43. PubMed ID: 9114118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.